CVR number 42506982
Industry 86.2200 Specialist medical practice activities

Speciallæge Mogens Pfeiffer Jensen ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  0.0% 0.0% 1.2% 1.1% 0.9%  
Credit score (0-100)  0 0 82 85 89  
Credit rating  N/A N/A A A A  
Credit limit (kDKK)  0.0 0.0 57.2 178.2 424.5  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 2,206 3,528 4,542  
EBITDA  0.0 0.0 1,222 2,058 2,180  
EBIT  0.0 0.0 1,062 1,837 1,939  
Pre-tax profit (PTP)  0.0 0.0 941.5 1,732.6 1,916.8  
Net earnings  0.0 0.0 733.1 1,350.9 1,494.6  
Pre-tax profit without non-rec. items  0.0 0.0 942 1,733 1,917  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 125 313 234  
Shareholders equity total  0.0 0.0 773 2,010 3,386  
Interest-bearing liabilities  0.0 0.0 3,313 1,421 0.0  
Balance sheet total (assets)  0.0 0.0 4,002 4,354 4,821  
Net Debt  0.0 0.0 2,829 713 -785  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 2,206 3,528 4,542  
Gross profit growth  0.0% 0.0% 0.0% 59.9% 28.8%  
Employees  0 0 1 2 2  
Employee growth %  0.0% 0.0% 0.0% 100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 4,002 4,354 4,821  
Balance sheet change%  0.0% 0.0% 0.0% 8.8% 10.7%  
Added value  0.0 0.0 1,222.3 1,997.2 2,180.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 3,069 -194 -483  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 1.0 2.0 3.0  

Profitability 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 48.2% 52.1% 42.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 26.5% 44.0% 42.7%  
ROI %  0.0% 0.0% 25.5% 47.5% 54.7%  
ROE %  0.0% 0.0% 94.8% 97.1% 55.4%  

Solidity 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  0.0% 0.0% 19.3% 46.2% 70.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 231.4% 34.6% -36.0%  
Gearing %  0.0% 0.0% 428.5% 70.7% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 7.3% 4.4% 6.2%  

Liquidity 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.0 0.0 0.9 0.4 0.9  
Current Ratio  0.0 0.0 0.9 0.4 0.9  
Cash and cash equivalent  0.0 0.0 483.7 708.3 785.3  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -113.1 -1,229.7 -133.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 1,222 999 1,090  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 1,222 1,029 1,090  
EBIT / employee  0 0 1,062 919 970  
Net earnings / employee  0 0 733 675 747